{
    "2020-01-10": [
        [
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)半年度净利润降27.6%至6149.11万元拟10派0.2元 盈利能力下降",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利润下降",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：多个产品在多个国家开展了产品注册",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "产品注册",
                        "国际市场"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[公司]沃森生物：正式收到13价肺炎疫苗药品注册批件",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "13价肺炎疫苗",
                        "药品注册批件"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-01-10",
                "original_text": "1月10日晚间上市公司十大重磅公告",
                "features": {
                    "keywords": [
                        "上市公司",
                        "重磅公告"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：公司13价肺炎球菌多糖结合疫苗收到药品注册批件",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "13价肺炎疫苗",
                        "药品注册批件"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "盈利预增620%，新疫苗上市首年销售16亿元！这家公司绝地反击？",
                "features": {
                    "keywords": [
                        "盈利预增",
                        "新疫苗",
                        "销售增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物自主研发国内首个13价肺炎球菌多糖结合疫苗获批准上市",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "自主研发",
                        "13价肺炎疫苗",
                        "批准上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "沃森13价肺炎球菌多糖结合疫苗获批准上市 打破欧美公司20年垄断",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "13价肺炎疫苗",
                        "打破垄断"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "“中国疫苗”走出门口：借WHO预认证东风 助力“一带一路”沿线疾病防控",
                "features": {
                    "keywords": [
                        "中国疫苗",
                        "WHO预认证",
                        "一带一路",
                        "疾病防控"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "国际关系"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}